tradingkey.logo
搜索

QuidelOrtho Corp

QDEL
添加自选
18.250USD
+0.070+0.39%
收盘 07/02, 13:00美东报价延迟15分钟
1.24B总市值
亏损市盈率 TTM

关于 QuidelOrtho Corp 公司

QuidelOrtho Corporation provides in vitro diagnostics, developing and manufacturing intelligent solutions. The Company specializes in immunoassay and molecular testing, clinical chemistry and transfusion medicine. Its business units include labs, molecular diagnostics, point of care and transfusion medicine. Under the labs business unit, its product categories include virology & bioassays, specialty products, VITROS platform and immunodiagnostics. Under the molecular diagnostics business unit, its product categories include Lyra, Solana and Savanna. Under the point of care business unit, its product categories include rapid immunoassay and cardiometabolic immunoassay. Under the transfusion medicine business unit, its product categories include immunohematology and donor screening. It provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics and Ortho Optix.

QuidelOrtho Corp简介

公司代码QDEL
公司名称QuidelOrtho Corp
上市日期Feb 01, 1991
CEOBlaser (Brian J)
员工数量6600
证券类型Ordinary Share
年结日Feb 01
公司地址9975 Summers Ridge Road
城市SAN DIEGO
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编92121
电话18585521100
网址https://www.quidelortho.com/
公司代码QDEL
上市日期Feb 01, 1991
CEOBlaser (Brian J)

QuidelOrtho Corp公司高管

名称
名称/职务
职务
持股
持股变动
Dr. Kenneth F. Buechler, Ph.D.
Dr. Kenneth F. Buechler, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
113.39K
+1.90%
Dr. Matthew W. Strobeck, Ph.D.
Dr. Matthew W. Strobeck, Ph.D.
Independent Director
Independent Director
89.38K
+7.64%
Mr. Brian J. Blaser
Mr. Brian J. Blaser
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
75.72K
+13.88%
Mr. Joseph M. Busky
Mr. Joseph M. Busky
Chief Financial Officer
Chief Financial Officer
55.11K
+14.77%
Ms. Michelle A. Hodges, J.D.
Ms. Michelle A. Hodges, J.D.
Senior Vice President, Corporate Secretary, Chief Legal Officer
Senior Vice President, Corporate Secretary, Chief Legal Officer
43.18K
+4.96%
Mr. Edward L. (Ed) Michael
Mr. Edward L. (Ed) Michael
Independent Director
Independent Director
29.43K
+4.25%
Ms. Ann D. Rhoads
Ms. Ann D. Rhoads
Independent Director
Independent Director
23.26K
+35.41%
Mr. John R. Chiminski
Mr. John R. Chiminski
Independent Director
Independent Director
9.35K
+73.02%
Dr. Mary Lake Polan, M.D., Ph.D.
Dr. Mary Lake Polan, M.D., Ph.D.
Independent Director
Independent Director
--
--
Dr. Kenneth Jon (Ken) Widder, M.D.
Dr. Kenneth Jon (Ken) Widder, M.D.
Independent Director
Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Dr. Kenneth F. Buechler, Ph.D.
Dr. Kenneth F. Buechler, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
113.39K
+1.90%
Dr. Matthew W. Strobeck, Ph.D.
Dr. Matthew W. Strobeck, Ph.D.
Independent Director
Independent Director
89.38K
+7.64%
Mr. Brian J. Blaser
Mr. Brian J. Blaser
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
75.72K
+13.88%
Mr. Joseph M. Busky
Mr. Joseph M. Busky
Chief Financial Officer
Chief Financial Officer
55.11K
+14.77%
Ms. Michelle A. Hodges, J.D.
Ms. Michelle A. Hodges, J.D.
Senior Vice President, Corporate Secretary, Chief Legal Officer
Senior Vice President, Corporate Secretary, Chief Legal Officer
43.18K
+4.96%
Mr. Edward L. (Ed) Michael
Mr. Edward L. (Ed) Michael
Independent Director
Independent Director
29.43K
+4.25%

常见问题

QuidelOrtho Corp的前五大股东是谁?

QuidelOrtho Corp 的前五大股东如下:Dr. Kenneth F. Buechler, Ph.D.

有多少机构持有QuidelOrtho Corp(QDEL)的股份?

截至2026Q1,共有619家机构持有QuidelOrtho Corp的股份,合计持有的股份价值约为88.33M,占公司总股份的129.53%。与2025Q4相比,机构持股有所增加,增幅为-14180850.00。

哪个业务部门对QuidelOrtho Corp的收入贡献最大?

在2026Q1,Labs业务部门对QuidelOrtho Corp的收入贡献最大,创收373.80M,占总收入的53.41%。